Ankur,R. and Shahjad, A.(2012).  Alloxan Induced Diabetes: Mechanisms and Effects. IJRPBS. 3(2): 819-823.

Brownlee, M.(2005). The pathobiology of diabetic complications: a unifying mechanism. Diabetes.54(6): 1615-25.

Buege, J.A. and Aust, S.D. (1979). Microsomal lipid peroxidation. Methods Enzymol. 52: 302-310.

Busari, A.A., Adejare, A.A., Kelani, S.O., Imam, K.O., Awesu, A.A., Adefila, S. I. (2020). Comparative pre- and post-treatment effects of Nigella sativa oil on lipid profile and antioxidant enzymes in a rat model of diabetes mellitus. Niger J Med. 29:415-21.

Cersosimo, E., Garlick, P. and Ferretti, J. (2000). Renal substrate metabolism and gluconeogenesis during hypoglycemia in humans. Diabetes. 49: 1186-1193

Chance, B. and Maehly, A.C. (1955). Assay of catalase and peroxidase. Methods Enzymology II. 2: 764–775.

Chernyukh, O.G., Dikal, M.V. andGerushi, V.(2019). Possible mechanisms of metabolic changes of biochemical metabolism in the conditions of experimental alloxan-induced diabetes mellitus (DM).  IJPSR.10(11): 4806-4817.

Cohen ,G.J., Dembiec, D. and Marcus, J. (1970). Measurement of catalase activity in tissue extracts.  Ann.  Biochem.34:30-38.

Dinesh, K.J. and Raj K. A. (2011). Anomalies in alloxan-induced diabetic model: It is better to standardize it first.  Indian J Pharmacol.  43(1): 91.

Dunn, J.S., Sheehan, H.L. and Mclethie, N.G.B. (1943). Necrosis of islets of Langerhans produced experimentally. Lancet.1: 484-487.

Godin, D.V., Wohaieb, S.A., Garnett, M.E. and Goumeniouk, A.D. (1988). Antioxidant enzyme alterations in experimental and clinical diabetes. Mol Cell Biochem.84: 223–231.

Kaleem, M, Sheema, Sarmad, H., and Bano, B. (2005). “Protective effects of Piper nigrum and Vinca rosea in alloxan induced diabetic rats”. Indian J PhysiolPharmacol. 49 (1): 65–71.

Kubisch,  H.M., Wang, J., Bray, T.M. and Phillips, J.P. (1997). Targeted overexpression of Cu/Zn superoxide dismutase protects pancreatic b-cells against oxidative stress. Diabetes.46:1563-1566.

Lenzen, S.,(2008). The mechanisms of alloxan- and streptozotocin-induced diabetes. Diabetologia.51: 216–226.

Liamis, G., Liberopoulos E., Barkas, F. andElisaf, M. (2014).  Diabetes mellitus and electrolyte disorders. World J Clin Cases. 16, 2(10): 488-496

Lucchesi, A.N., Cassettari, L.L. and Spadella, C.T.(2015). Alloxan-induced diabetes causes morphological and ultrastructural changes in rat liver that resemble the natural history of chronic fatty liver disease in humans. Journal of Diabetes Research. 2015: 1-11.

Matkovics, B., Varga, S.Z.I., Szabo, L. and Witas, H. (1982). The effect of diabetes on the activities of the peroxide metabolism enzymes. HormMetab Res.14: 77–79.

Mohamed, J., Nafizah, N.A.H., Zariyantey, A.H. andBudin, S.B. (2016). Mechanisms of Diabetes-Induced Liver Damage:The role of oxidative stress and inflammation. Sultan Qaboos University Med J. 16(2):132-141.

Monika, M. and Umme, A. (2012). Alloxan: An unpredictable drug for diabetes induction.Indian J Pharmacol44(4):538–539.

Mukherjee, B., Mukherjee, J.R. and Chatterjee, M.,(1994). Lipid peroxidation, glutathione levels and changes in glutathione related enzyme activities in streptozotocin induced diabetic rats. Immun Cell Biol.72:109–14.

National Institute of Health, Institutional Animal Care and use Committee Guidebook. NIH Publication. Washington, D. C: U.S. Government Printing Office. 1992: 92-345.

Osibemhe, M., Lawal, N., Umar, D., Omaji, G.O.andJibiya, S.A.(2017). Effect of aqueous extract of Anisopusmanniin alloxan-induced diabetic rats. Sc. Word J.12(3):1597-6343.

Osibemhe, M., Orji,  B.O., Omaji,  G.O., Amune, E. and Ezekiel,  J. (2023). Instability of alloxan-induced diabetes and its impact on sex and thyroid hormones in male Wistar rats-a pilot study. Kuwait J. Sci. 50(1A): 1-11. DOI: 10.48129/kjs.15291

Pierre-Louis, T., Aude, F. and Alain, B.(2010).Species differences in pharmacokinetics and pharmacodynamics. Handb Exp. Pharmacol.199: 19-48.

Soni, Mishra, A.N. andUpendrakumar, (2019). “Alloxan Not an Ideal Drug for Diabetes Induction.”IOSR-JDMS18(6): 14-17.

Szaleczky, E., Prechl, J., Fehér, J. and Somogyi,  A.(1999). Alterations in enzymatic antioxidant defence in diabetes mellitus - a rational approach. Postgrad Med J. 75:13–17.

Szkudelski, T.(2001). The Mechanism of Alloxan and Streptozotocin Action in beta Cells of the Rat Pancreas. Physiol Res.50:536-46.

Tiedge, M., Lortz, S., Munday, R. andLenzen, S.(1998). Complementary action of antioxidant  enzymes in the protection of bioengineered insulin-producing RINm5F cells against the toxicity of reactive oxygen species. Diabetes.47: 1578-1585.

Umar, S.A., Mohammed, Z., Nuhu, A., Musa, K.U.andTanko, Y. (2018). Evaluation of hypoglycaemic and antioxidant activity of Moringa oleifera Root in Normal and Alloxan-Induced Diabetic Rats. Tropical Journal of Natural Product Research. 2(8): 401- 408.

Valko, M., Leibfritz, D., Moncola, J. and Cronin, M. D. (2007). Free radicals and

antioxidants in normal physiological functions and human disease. Rev Int J Biochem Cell

Biol.39: 44–84.

Wohaieb, S.A. andGodin, D.V. (1987).  Alterations in free radical tissue defense mechanisms in streptozotocin induced diabetes in rat. Diabetes.36: 1014–1018.

Zhao, Z.H., Watschinger, B., Brown, C.D., Beyer, M.M. and Friedman, E.A. (1987). Variations of susceptibility to alloxan induced diabetes in the rabbit. Horm Metab Res.19: 534-537.